Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans

被引:17
作者
Serreze, DV [1 ]
Chen, YG [1 ]
机构
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
关键词
D O I
10.1016/j.it.2005.08.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Animal model and clinical studies indicate that type 1 diabetes (T1D) results from T cell-mediated autoimmune destruction of insulin-producing pancreatic beta-cells. This review discusses the knowledge gained from animal models about the nature of the autoreactive T cells that cause T1D and the possible basis for their development. Based on this information, the possible positive and negative aspects of various antigen-specific and nonspecific immunotherapies, which could potentially prevent the onset of T1D in at risk individuals, are discussed.
引用
收藏
页码:603 / 607
页数:5
相关论文
共 64 条
[1]   Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells [J].
Albert, ML ;
Jegathesan, M ;
Darnell, RB .
NATURE IMMUNOLOGY, 2001, 2 (11) :1010-1017
[2]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[3]   INSULITIS AND DIABETES IN NOD MICE REDUCED BY PROPHYLACTIC INSULIN THERAPY [J].
ATKINSON, MA ;
MACLAREN, NK ;
LUCHETTA, R .
DIABETES, 1990, 39 (08) :933-937
[4]   Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants [J].
Beilhack, GF ;
Landa, RR ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2005, 54 (06) :1770-1779
[5]   Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice [J].
Beilhack, GF ;
Scheffold, YC ;
Weissman, IL ;
Taylor, C ;
Jerabek, L ;
Burge, MJ ;
Masek, MA ;
Shizuru, JA .
DIABETES, 2003, 52 (01) :59-68
[6]   Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic β-cells [J].
Bridgett, M ;
Cetkovic-Cvrlje, M ;
O'Rourke, R ;
Shi, YG ;
Narayanswami, S ;
Lambert, J ;
Ramiya, V ;
Baekkeskov, S ;
Leiter, EH .
DIABETES, 1998, 47 (12) :1848-1856
[7]   Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes [J].
Chen, YG ;
Choisy-Rossi, CM ;
Holl, TM ;
Chapman, HD ;
Besra, GS ;
Porcelli, SA ;
Shaffer, DJ ;
Roopenian, D ;
Wilson, SB ;
Serreze, DV .
JOURNAL OF IMMUNOLOGY, 2005, 174 (03) :1196-1204
[8]   Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience [J].
Choisy-Rossi, CM ;
Holl, TM ;
Pierce, MA ;
Chapman, HD ;
Serreze, DV .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3791-3800
[9]   Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation [J].
Dahlén, E ;
Hedlund, G ;
Dawe, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2444-2456
[10]   Endocrine autoantibodies [J].
Devendra, D ;
Yu, LP ;
Eisenbarth, GS .
CLINICS IN LABORATORY MEDICINE, 2004, 24 (01) :275-+